The newly committed suite is the first of four manufacturing suites ProMed is constructing at Niagara Lane to support growing demand for manufacture of ophthalmic implants and other sustained-release ...
Triazoles are privileged five-membered aromatic heterocycles featuring three consecutive nitrogen atoms, and have emerged as versatile scaffolds in ...
MIT researchers are now turning the prolific Boltz series of models into a software company that promotes open science for AI-guided therapeutics.
The Singapore-based AI clinical trial engine powering Asia’s—especially China’s—rapid rise in the biotech industry. Deep ...
Enter generative AI, which the pharma industry is adopting at a terrific rate. By ingesting and analysing vast biological ...
Barnes Asphalt Maintenance Inc. has reached its 30-year milestone, a significant achievement in an industry where contractor ...
BostonGene has entered a new collaboration with AstraZeneca to apply its foundation AI model to oncology drug development, aiming to improve early trial decision-making around safety, efficacy, and ...
US security policy in Latin America and the Caribbean under President Trump has moved towards a militarized and repressive ...
Zebrafish (Danio Rerio) have emerged as a powerful bioengineering platform for next-generation drug discovery, offering an unparalleled combination of ...
Insilico now has a pipeline of more than 40 AI-developed drugs it is developing for conditions such as cancer, bowel and kidney disease.
Avinasi Labs Enables a New Funding & Revenue Model for Clinical Stage Assets via DeLong Protocol SAN FRANCISCO, CA, UNITED STATES, December 31, 2025 /EINPresswire.com/ — Avinasi Labs, an AI-native ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results